SubscribeRegistration Is Limited To 50 For Three-Day Training Course, May 8-10, 2006.
The Drug Information Association (DIA) will host a three-day training course with members of the scientific and pharmaceutical community to discuss regulatory requirements for drug development and pertinent regulatory processes and forms for INDs.
The course will be offered May 8-10 at the Hyatt Regency Princeton, in Princeton, New Jersey.
Designed to target newly hired regulatory affairs professionals and pharmaceutical industry professionals new to the IND process, the program will give participants the tools to understand and discuss the role of regulatory affairs within the industry; how the FDA's review teams operate; how to report any problems that occur during clinical trials to FDA and investigators; and, what etiquette applies when dealing with the FDA during the IND phase.
The limited scope of this hands-on meeting offers an ideal setting for meaningful interactive dialogue between attendees and presenters during sessions.
Register online at www.diahome.org and download the program at http://www.diahome.org/product/11028/06436.pdf.
For more information about the meeting, contact Jenna Hannum, DIA's program manager at (215) 442-6100, or Jenna.Hannum@diahome.org. Media interested in attending the event or arranging for pre- or post-event interviews should contact Megan Smith (megan@toplin.com) at (215) 793-4666.
Philadelphia - March 1, 2006